Medical Equipment //

NHS Scotland Adopts Five New Medicines

New medicines to treat kidney and breast cancer are among five new treatments which have now been approved for use within NHS Scotland, by the Scottish Medicines Consortium (SMC).

New Medicines

Ribociclib (Kisqali) used to treat breast cancer, Lenvatinib (Kisplyx) for kidney cancer, pentosan polysulfate sodium (Elmiron) which is used for bladder pain syndrome, Clostridium botulinum neurotoxin type A (Xeomin) for treatment of excessive drooling, and imiquimod (Zyclara) used to treat actinic keratosis, have all been accepted for use within the NHS after the SMC’s committee members heard a range of evidence on the medicines.

Continue Reading

To access this content please register.

Register for Free

Already a member? Login

Please register or login to comment!

Register now Login

Select a page to copy this section to:

Select where in the level you want it inserted: